Date archive for June 25th, 2012
Hardly a day goes by before I see an alert for yet another insider purchase at Opko Health (OPK) by its Chairman and CEO Dr. Phillip Frost. After months of reporting on these purchases, we decided to do a deep dive to understand the company and Dr. Frost’s motivations for buying the stock as best as possible. With less than a week to work on this article and the fact that Opko is a holding company for various pharma, diagnostics and biotech companies, this could be considered a preliminary report instead of a comprehensive research piece.
It is often ...
The rest of this report is only accessible to Insider Trade Reports Subscribers. Click here to subscribe to Insider Trade Reports